NLM Digital Collections

Search

Start Over Subjects Disclosure ✖Remove constraint Subjects: Disclosure Copyright Public domain ✖Remove constraint Copyright: Public domain Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

2. Health care price transparency and price competition

Publication:
Washington, D.C. : George Washington University, [2007]
Subject(s):
Disclosure
Economic Competition
Health Care Costs
Community Participation -- economics
Contract Services -- economics
Cost Sharing -- economics
Costs and Cost Analysis -- standards
Deductibles and Coinsurance -- economics
Government
Health Benefit Plans, Employee -- economics
Medical Savings Accounts -- economics
Medicare
Preferred Provider Organizations -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)
Medicare Payment Advisory Commission (U.S.)

3. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 2017
Subject(s):
Air Ambulances -- economics
Fees and Charges
Insurance Coverage -- economics
Cost Sharing
Data Collection
Disclosure
Government Regulation
Humans
United States
United States. Department of Transportation.
Centers for Medicare & Medicaid Services (U.S.)

4. Private school choice: federal actions needed to ensure parents are notified about changes in rights for students with disabilities : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, November 2017
Subject(s):
Civil Rights
Disabled Children -- legislation & jurisprudence
Schools -- legislation & jurisprudence
Students -- legislation & jurisprudence
Disclosure
Federal Government
Financing, Government
Parents
Private Sector
Public Sector
Humans
United States

5. COVID-19: federal efforts accelerate vaccine and therapeutic development, but more transparency needed on emergency use authorizations : report to Congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, November 2020
Subject(s):
COVID-19 Vaccines
Drug Approval
Drug Development
Disclosure
United States
United States. Department of Defense
United States. Department of Health and Human Services

6. Presenting quantitative efficacy and risk information in direct-to-consumer (DTC) promotional labeling and advertisements: guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, June 2023
Subject(s):
Direct-to-Consumer Advertising -- legislation & jurisprudence
Direct-to-Consumer Advertising -- standards
Disclosure
Drug Industry
Drug Labeling -- legislation & jurisprudence
Drug Labeling -- standards
Government Regulation
United States